🔎 Trials Near Me

Home › Prostate Cancer › NCT06138067

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Recruiting

A Pilot Study of Low Versus High Intensity Patient Navigation Program to Improve the Enrollment on Clinical Trials Among Cancer Patients

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
1. Age ≥ 18 years
2. Patient with a current diagnosis of a primary solid tumor including: prostate cancer and kidney cancer
3. Being seen at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University (JHU) or Wellspan Health Center
4. Available therapeutic trial for the patient as determined through pre-screening/medical record review

About the study

The goal of this clinical trial is to test the utility of patient navigation by comparing high intensity patient navigation to low intensity navigation approaches to improving cancer trial enrollment of patients treated in academic and community cancer centers. Patient navigation is a strategy for increasing patients access to cancer care by helping the participant overcome barriers in the participants communities and within the health care system by providing a bridge between the patient and the health care system. The primary objective of this study is to determine if a high intensity patient navigation program will improve patients enrollment on clinical trial in comparison to a low intensity patient navigation. Participants who agree to participate and are eligible will be randomly assigned to either the high intensity or low intensity approach.

What is being tested

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Participants: 90 · Started: Dec 1, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06138067

Locations in the U.S.

MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
PennsylvaniaWellspan, Chambersburg (Not yet recruiting)

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.